Cixutumumab and Sorafenib Tosylate in Treating Patients With Advanced Liver Cancer

Clinical trial NCT01008566 · COMPLETED

Trial details

NCT number: NCT01008566
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Adult Hepatocellular Carcinoma Advanced Adult Hepatocellular Carcinoma Localized Non-Resectable Adult Liver Carcinoma Recurrent Adult Liver Carcinoma

Start date: 2009-08-01
Primary completion: 2016-05-01
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.